Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways of diagnosing and treating the disease.| ALS News Today
Certain rare genetic variants tied to Parkinson’s and other diseases raise the risk of developing ALS by more than three times, per a study.| ALS News Today
The first patient has been dosed in an open-label Phase 1/2 clinical trial of AMT-162, uniQure's one-time gene therapy for SOD1-ALS.| ALS News Today
Category archive page for News.| ALS News Today
Margarida Maia is a science writer for ALS News Today with a PhD in biomedical sciences. She covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today